Human Comedogenicity Test
Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
This NA trial investigates Comedogenicity and is currently completed. Johnson & Johnson Consumer Inc. (J&JCI) leads this study, which shows 12 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Aug 2023 — Jul 2024 [monthly]
Completed NA
-
Sep 2022 — Aug 2023 [monthly]
Completed NA
-
Jan 2021 — Sep 2022 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Completed NA
-
Feb 2020 — Dec 2020 [monthly]
Completed NA
-
Sep 2019 — Feb 2020 [monthly]
Completed NA
Status: Withheld → Completed · Phase: None → NA
-
Jul 2018 — Sep 2019 [monthly]
Withheld
-
Jun 2018 — Jul 2018 [monthly]
Withheld
-
Apr 2018 — Jun 2018 [monthly]
Withheld
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Withheld NA
First recorded
Nov 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johnson & Johnson Consumer Inc. (J&JCI)
For direct contact, visit the study record on ClinicalTrials.gov .